PHARMA PATIENT ACCESS WORLD CONGRESS 2025 EUROPE
Improving Patient Access for Better Health Outcomes and Quality of Life
Copthorne Tara Hotel London Kensington, London, UK, London, United Kingdom
Day 2 - Thursday 12th June 2025
- Auditorium 1
CHALLENGES & OPPORTUNITIES
- Understand the cause of health inequalities and how they affect the community
- Causes of health inequalities
- How do health inequalities impact health and wellbeing?
- How companies can address health equity through people and patient engagement;
- Success measures of efforts to advance health equity
- What can the industry do to promote health equity in the future?
Moderator:
Panelists:
- Structural interventions that have yielded health benefits
- Challenges and opportunities to advance improvements in minority health
- Recommendations to encourage the development of structural interventions likely to advance health disparities research
- Acquiring good quality data is essential in providing insights that can bring about improvement and reduce disparities
- Focussing on implementation, impact and evaluation
- Areas of focus for patient advocacy partnerships
- Best practice in working together to produce better outcomes for patients
- Benefits of working together
- Embracing a patient-centric mindset and keep the patient front of mind
- How to interact in every way with the groups that represent those patients
- Discover how telehealth can make healthcare more accessible
- Understanding patient perspectives on telemedicine crucial for its adoption and efficacy.
- Key recommendations for telemedicine optimization and equity
- Continuous evaluation and adaptation essential to address technological challenges and disparities in telehealth usage
- Using artificial intelligence (AI) to address barriers to Patient Access
- How can data and AI be utilised to promote access?
- How can AI tools make it easier and more affordable for patients to receive needed care?
- Potential to revolutionise the healthcare industry further
- Importance of early consideration and integration of RWE into market access and commercialization strategies
- How and where to access real-world Data?
- Leveraging existing data sources and technologies to enhance study quality and streamline processes
- Robust planning and interpretation methods for effective utilisation of data for driving evidence-based decision making
- Primary barriers why patients struggle to access the therapies they need
- Proactive steps life sciences companies can take to address these barriers
- Impact of Not overcoming Patient Access hurdles
- What Is pharma value and what should you know about it?
- Benefits of payer value proposition
- How to design an equitable value prepositions?
- Examples of Payer Value Proposition in Pharma
- Recommendations to enhance value assessment and recognition
- Strategies to improve implementation
- Optimising the benefits of value-based pricing, through complementary tools
- Understanding the intricacies of pharma reimbursement
- Reimbursement hurdles that impact market access of launching new therapies and patient access
- The impact of Health Technology Assessment in reimbursement
- A successful pharma reimbursement strategy
- Future trends in reimbursement
- Addressing the unequal access to medicines for patients across Europe
- Disparities in the time it takes for European patients to access new medicines persist
- Factors causing delays and barriers to access
- Stakeholders collaboration towards pragmatic solutions that work for patients and help address Europe’s health inequalities.
Moderator:
Panelists:
- Robust market access strategy to help ensure that pharmaceutical innovations benefit the widest population possible
- Rigorous, proactive methodologies to support reimbursement
- Effective approach guided by patient-centricity to ensure patients receive timely treatment.
- Continuous medical education resulting in better clinical outcomes for patients and improved physician performance
Moderator:
Panelists: